Pilomatrixoma (calcifying epithelioma of Malherbe) is a benign skin appendageal tumor with differentiation towards hair follicle matrix cells. This lesion occurs over a wide age range with two peaks: less than 20 years and over 50 years [
7]. Pilomatrixoma is typically found in head and neck region, though it has been reported in upper extremities and other sites. In a large series of 346 pilomatrixomas, about 15.3% were seen in upper extremities [
8]. There have been few reports of pilomatrixoma occurring in the arm in the existing literature [
1–
4]. Clinically, pilomatrixoma presents as solitary painless and well circumscribed dermal or subcutaneous mass upto 3

cm in diameter [
9]. The overlying skin may display telangiectasia, hemangioma-like color, or blue-black discoloration [
10]. Our patient, a five-year girl, had a solitary firm lesion on the lateral aspect of left arm with no changes in the overlying skin.
Fine needle aspiration cytology (FNAC), the most favoured diagnostic modality in superficial masses, usually shows characteristic features of pilomatrixoma. These include basaloid cell clusters, shadow (ghost) cells, calcification, and few nucleated squamous cells. Giant cells may be seen in response to keratin [
5]. Despite these features, pilomatrixoma may be mistaken for other skin lesions [
6]. A previously reported case of pilomatrixoma of the arm was diagnosed cytologically as blue round cell tumor due to the presence of round to ovoid cells with occasional rosette-like appearance. Histopathology in this case showed features of pilomatrixoma [
3]. The authors suggested that early rapidly growing lesions, composed predominantly of basaloid cells, may lead to overdiagnosis of malignancy [
3].
Histologic features of pilomatrixoma are well described in the literature as a deep subepidermal tumor consisting of irregular islands of keratinized shadow cells surrounded by peripheral basaloid cells. Calcification may be seen in shadow cell regions along with foreign body giant cell reaction to keratin [
9].